Baseline Quantitative CT Predicts Rate of Decline in Forced Vital Capacity and Clinically Relevant Outcomes in Patients With Progressive Pulmonary Fibrosis: Results from the INBUILD Trial

作者
Peter M. George,Carina Ittrich,Anand Devaraj,Eric S. White,Jonathan Gerald Goldin,Olivier Joly,Susanne Stowasser,Frank Risse
出处
期刊:American Journal of Respiratory and Critical Care Medicine [American Thoracic Society]
卷期号:211 (Supplement_1): A7675-A7675 被引量:1
标识
DOI:10.1164/ajrccm.2025.211.abstracts.a7675
摘要

Abstract Rationale: In the placebo-controlled INBUILD trial, nintedanib reduced the rate of decline in forced vital capacity (FVC) over 52 weeks compared with placebo in subjects with progressive pulmonary fibrosis (PPF). We used standardized non-contrast high resolution computed tomography (HRCT) data to investigate the potential of two separate quantitative imaging analysis methods to prognosticate subsequent rate of decline in FVC and time-to-event timepoints. Methods: Subjects had an ILD other than idiopathic pulmonary fibrosis and an extent of fibrosis on HRCT >10%. HRCT scans acquired within 85 days of start of treatment were defined as baseline scans. In the placebo group, we analyzed quantitative extent of interstitial lung disease (QILD) using an established quantitative CT method and total disease extent (TDE), weighted reticulovascular score (WRVS) using Brainomix e-Lung. Analyses of prognostic potential of continuous baseline quantitative CT assessments for rate of decline over 52 weeks in FVC [mL/year] were based on a random coefficient regression model. The prognostic potential of dichotomized baseline quantitative CT assessments for time-to-death and the composite of time-to-death or absolute decline in FVC % predicted >10% as a measure of disease progression were analyzed using Cox regression models. Median values of quantitative CT parameters at baseline were used as cut-offs. Results: 257 subjects in the placebo group had QILD scores and 192 had TDE and WRVS at baseline. Estimates for the rate of decline in FVC are presented in the table. Subjects with ≥34.0% extent of QILD or ≥20.9% TDE had a significantly increased risk (HR 2.14 (1.40, 3.28), p=0.0004 and HR 1.87 (1.16, 3.01), p=0.0105, respectively) of disease progression within one year. Using these same cutoffs, subjects had a significantly increased risk (HR 3.22 (1.57, 6.58), p=0.0014 and HR 3.50 (1.44, 8.47), p=0.0056) of death over the whole trial. Subjects with a median WRVS of 14.9% had a significantly increased risk of disease progression within one year as well as a significantly increased risk of mortality during the trial (HR=2.10 (1.28, 3.45), p=0.0034 and HR=2.90 (1.14, 7.37), p=0.0256). Conclusion: Quantitative CT, independent of the method used, was able to predict the rate of decline in FVC over 52 weeks and time-to-disease progression or death based on the single point estimate of percentage of lung affected at baseline in a PPF study population. These results encourage the application of quantitative CT in routine clinical practice for prognostic use as well as in clinical trials for patient selection.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
xiaoxiao完成签到 ,获得积分10
刚刚
momo完成签到 ,获得积分10
1秒前
风格完成签到,获得积分10
10秒前
10秒前
水煮电吹风的应助被雪山飞龙采纳,获得10
11秒前
醉酒当歌完成签到 ,获得积分10
12秒前
侯子完成签到 ,获得积分10
12秒前
追寻微笑完成签到 ,获得积分10
12秒前
勤劳的唇膏完成签到,获得积分10
16秒前
taowenquan完成签到 ,获得积分10
23秒前
旅行者N0501完成签到,获得积分10
25秒前
灵巧的长颈鹿完成签到,获得积分10
31秒前
怼怼完成签到 ,获得积分10
33秒前
nikki完成签到 ,获得积分10
33秒前
马伯乐完成签到 ,获得积分10
34秒前
Hello的应助被豆豆采纳,获得10
34秒前
38秒前
动人的冷霜完成签到,获得积分10
39秒前
迅速的新竹完成签到,获得积分10
39秒前
Peiqi的应助被雪山飞龙采纳,获得10
42秒前
44秒前
蓝精灵完成签到,获得积分10
46秒前
yuki完成签到 ,获得积分10
46秒前
漾漾的羊完成签到 ,获得积分10
48秒前
dianeil完成签到,获得积分10
56秒前
王不凡完成签到 ,获得积分10
58秒前
LWJ完成签到 ,获得积分10
58秒前
竹舍翁暮雨君完成签到 ,获得积分10
1分钟前
机智的孤兰完成签到 ,获得积分10
1分钟前
拼搏忆文完成签到,获得积分10
1分钟前
康康舞曲完成签到 ,获得积分10
1分钟前
XU博士完成签到,获得积分10
1分钟前
轻歌水越完成签到 ,获得积分10
1分钟前
风趣朝雪完成签到,获得积分10
1分钟前
Robin完成签到 ,获得积分10
1分钟前
一瓣橘子完成签到,获得积分10
1分钟前
kk完成签到,获得积分10
1分钟前
Fan完成签到 ,获得积分0
1分钟前
蔡勇强完成签到 ,获得积分10
1分钟前
bo完成签到 ,获得积分0
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180053
求助须知:如何正确求助?哪些是违规求助? 9570224
关于积分的说明 21808682
捐赠科研通 7776054
什么是DOI,文献DOI怎么找? 3433261
关于科研通互助平台的介绍 2557425
邀请新用户注册赠送积分活动 2479012